Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,473.47
(
0.37%
)
US TECH 100
28,612.40
(
0.11%
)
Dow Jones
50,579.70
(
0.58%
)
Brent Oil
101.17
(
0.00%
)
Bitcoin
77,057.33
(
0.06%
)
News Focus
News Focus
Post# of 257624
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123010
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 95786

Sunday, 05/16/2010 9:07:46 PM

Sunday, May 16, 2010 9:07:46 PM

Post# of 257624
Given the interest in HCV in these parts, I’m surprised no one has commented on the comments in #msg-50187183. Is MRK pulling a fast one on the investment community by touting a Boceprevir NDA submission in 2010 while internally planning for an FDA decision to be delayed until 2012 or 2013? (This is a serious question, not a rhetorical one.)


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today